Background: The resistance pattern of uropathogens is increasing very rapidly because of the unsorted, insufficient, and incoherent usage of antibiotics. The aim of this study was to evaluate the prevalence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) uropathogens which were isolated from the urinary tract infection (UTI) cases in Dhaka, Bangladesh. Methods: In this cross-sectional study, a total of 21167 urine samples were collected from January 2016 to December 2018, followed by using conventional methods, as well as Kirby-Bauer disc diffusion method for urine culture and susceptibility, respectively. Finally, SPSS software was utilized to analyze the obtained data. Results: From among 21167 urine samples, 2469 (11.66%) cases were bacteriologically positive. In UTI cases, males proportion were higher compared to females (in ≤ 10 and > 60 to ≤90 years age groups) and females in the age groups between 10 and 60 and >90 years suffered more than males (P<0.05). In addition, 172 (7.0%), 1337 (54.2%), and 845 (34.2%) cases were identified as XDR, single drug-resistance (SDR), and nondrug-resistance (NDR), respectively. Although the number of female XDR cases was higher than males, the percentages of male cases were higher compared to female cases in this study. The most predominant drugresistance cases (18.7%) were found in the age group between 21 and 30 years (P<0.05). Eventually, the isolates of Escherichia coli were the most prevalent cases that carried XDR (5.4%) and MDR (39.7%). Conclusions: In general, it is extremely alarming to increase XDR and MDR uropathogens. This bacterial resistance can be prevented through control measures that limit the spread of resistant bacteria and the regular monitoring of this resistance phenotype of uropathogens, along with the rational use of antimicrobial therapy.
29 January 2025 in Advances in Pharmacological and Pharmaceutical Sciences
Metformin is the most widely prescribed drug for the treatment of Type 2 diabetes mellitus (T2DM), but its response varies from person to person. This study aims to analyze the complete mutation spectrum of the OCT1 gene in metformin poor responders and to explore the potential pathogenic effects of the identified mutations. Clinical features of 56 Bangladeshi T2DM patients (who showed altered response to metformin) were analyzed, and genomic DNA was extracted from their blood samples. Subsequently, the entire exons (1–11), along with flanking introns of the OCT1 gene were amplified and sequenced. Molecular consequences of the identified mutations on OCT1 protein activity were determined through in silico analyses. In this study, 29 mutations of the OCT1 gene were identified; among which 5 mutations (c.412‐86G>T, c.970G>C, c.1386‐3088_1386‐3083delGAATCA, c.1498+66G>T, and c.1653C>A) were novel. It was found that nsSNPs c.181C>T, c.1022C>T, c.493G>T, c.1207A>G, and c.970G>C (novel) as well as frameshift deletions have potential deleterious effects on OCT1 protein stability and function. Some of these mutations also cause alternative splicing, as per the HSF tool. In addition, alteration of interatomic bonding in the OCT1 protein due to two high‐risk mutations (c.181C>T and c.1022C>T) was found from web‐based analysis. The mutations, as mentioned earlier, are the most probable causative factor of decreased metformin effectiveness and adverse side effects in T2DM patients who are poor responders. Understanding the OCT1 gene variations of patients can help tailor treatment strategies for optimal metformin response or identify alternative medications.
30 March 2024 in Avicenna Journal of Clinical Microbiology and Infection
Background: Rickettsial infection is one of the most frequently occurring neglected diseases, which can be life-threatening if left untreated. Hence, it is important to know the burden of the disease for taking appropriate preventive and control measures. This paper focused on the seroprevalence of rickettsial infection among hospitalized patients residing in the coastal area of Teknaf, Cox’s Bazar, Bangladesh. Methods: We retrospectively analyzed the hospital records of Weil-Felix test-positive patients from January to December 2022 at Respiratory Disease Hospital, Teknaf. A rapid slide agglutination assay, colorimetric method, KOVA cell counting, flow cytometry method, and SPSS were used for data analysis. The necessary ethical approval was obtained from the Institutional Reviewer Board for using the hospital records. Results: A total of 91 (16.9%) Rickettsia-positive cases were found out of 538 suspected cases, of which half were male (49.5%). The most predominant age group was 5 to under 18 years of age (41.7%), followed by 18‒30 years of age (23.1%). Fever was the most prominent clinical symptom (97.7%), followed by cough (42.9%), muscle aches (29.7%), and headaches (27.5%). The blood count of the patients showed leukocytosis (53.2%), followed by neutrophilia (23.4%) and thrombocytosis (15.6%). Serum creatinine and C-reactive protein were elevated in 13% and 40% of cases, respectively. Urine analysis detected the presence of high pus cells (83.9%), followed by proteinuria (45.2%) and ketonuria (13.0%). Conclusion: In-depth confirmatory exploration and preventive measures are necessary to manage and mitigate the spread of infections at Teknaf.